387 related articles for article (PubMed ID: 17530682)
1. Quality of care for gout in the US needs improvement.
Singh JA; Hodges JS; Toscano JP; Asch SM
Arthritis Rheum; 2007 Jun; 57(5):822-9. PubMed ID: 17530682
[TBL] [Abstract][Full Text] [Related]
2. Opportunities for improving medication use and monitoring in gout.
Singh JA; Hodges JS; Asch SM
Ann Rheum Dis; 2009 Aug; 68(8):1265-70. PubMed ID: 18701554
[TBL] [Abstract][Full Text] [Related]
3. A national survey of Veterans Affairs rheumatologists for relevance of quality of care indicators for gout management.
Singh JA; Alpert MD; Kerr G
Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1306-11. PubMed ID: 20235197
[TBL] [Abstract][Full Text] [Related]
4. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD).
Mikuls TR; Farrar JT; Bilker WB; Fernandes S; Saag KG
Rheumatology (Oxford); 2005 Aug; 44(8):1038-42. PubMed ID: 15870145
[TBL] [Abstract][Full Text] [Related]
5. Measuring physician adherence with gout quality indicators: a role for natural language processing.
Kerr GS; Richards JS; Nunziato CA; Patterson OV; DuVall SL; Aujero M; Maron D; Amdur R
Arthritis Care Res (Hoboken); 2015 Feb; 67(2):273-9. PubMed ID: 25047509
[TBL] [Abstract][Full Text] [Related]
6. Gout medication treatment patterns and adherence to standards of care from a managed care perspective.
Sarawate CA; Brewer KK; Yang W; Patel PA; Schumacher HR; Saag KG; Bakst AW
Mayo Clin Proc; 2006 Jul; 81(7):925-34. PubMed ID: 16835972
[TBL] [Abstract][Full Text] [Related]
7. Factors Influencing the Effectiveness of Allopurinol in Achieving and Sustaining Target Serum Urate in a US Veterans Affairs Gout Cohort.
Singh JA; Yang S; Saag KG
J Rheumatol; 2020 Mar; 47(3):449-460. PubMed ID: 31416925
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of Urate-Lowering Therapy Among US Veterans Following the 2012 American College of Rheumatology Guidelines for Management of Gout.
Hughes JC; Wallace JL; Bryant CL; Salvig BE; Fourakre TN; Stone WJ
Ann Pharmacother; 2017 Apr; 51(4):301-306. PubMed ID: 27881692
[TBL] [Abstract][Full Text] [Related]
9. A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift.
Khanna P; Khanna D; Storgard C; Baumgartner S; Morlock R
Postgrad Med; 2016 Jan; 128(1):34-40. PubMed ID: 26578028
[TBL] [Abstract][Full Text] [Related]
10. [Quality of treatment in gouty patients considering EULAR recommendations].
Radak-Perović M; Zlatković-Svenda M
Srp Arh Celok Lek; 2012; 140(11-12):717-21. PubMed ID: 23350244
[TBL] [Abstract][Full Text] [Related]
11. Evaluating appropriate use of prophylactic colchicine for gout flare prevention.
George M; Pullman-Mooar S; Hussain F; Schumacher HR
Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1258-62. PubMed ID: 24376081
[TBL] [Abstract][Full Text] [Related]
12. An open-label, 6-month study of allopurinol safety in gout: The LASSO study.
Becker MA; Fitz-Patrick D; Choi HK; Dalbeth N; Storgard C; Cravets M; Baumgartner S
Semin Arthritis Rheum; 2015 Oct; 45(2):174-83. PubMed ID: 26190562
[TBL] [Abstract][Full Text] [Related]
13. Clinical and health care use characteristics of patients newly starting allopurinol, febuxostat, and colchicine for the treatment of gout.
Kim SC; Schmidt BM; Franklin JM; Liu J; Solomon DH; Schneeweiss S
Arthritis Care Res (Hoboken); 2013 Dec; 65(12):2008-14. PubMed ID: 23861232
[TBL] [Abstract][Full Text] [Related]
14. The challenges of managing gout in primary care: Results of a best-practice audit.
Stamp LK; Chapman P; Hudson B; Frampton C; Hamilton G; Judd A
Aust J Gen Pract; 2019 Sep; 48(9):631-637. PubMed ID: 31476837
[TBL] [Abstract][Full Text] [Related]
15. Achieving treat to target in gout: a clinical practice improvement project.
Lim AY; Shen L; Tan CH; Lateef A; Lau TC; Teng GG
Scand J Rheumatol; 2012; 41(6):450-7. PubMed ID: 22839705
[TBL] [Abstract][Full Text] [Related]
16. Colchicine prescribing and safety monitoring in patients with gout.
Ly J; Gow P; Dalbeth N
N Z Med J; 2007 Nov; 120(1265):U2808. PubMed ID: 18264188
[TBL] [Abstract][Full Text] [Related]
17. Modifiable factors associated with allopurinol adherence and outcomes among patients with gout in an integrated healthcare system.
Rashid N; Coburn BW; Wu YL; Cheetham TC; Curtis JR; Saag KG; Mikuls TR
J Rheumatol; 2015 Mar; 42(3):504-12. PubMed ID: 25512479
[TBL] [Abstract][Full Text] [Related]
18. Treatment of gout.
Cohen MG
Intern Med J; 2011 Jan; 41(1a):70-1. PubMed ID: 21265967
[No Abstract] [Full Text] [Related]
19. Utility of Electronic Medical Records in Community Rheumatology Practice for Assessing Quality of Care Indicators for Gout: A Feasibility Study.
Estrada A; Tsao NW; Howren A; Esdaile JM; Shojania K; De Vera MA
J Clin Rheumatol; 2018 Mar; 24(2):75-79. PubMed ID: 29232325
[TBL] [Abstract][Full Text] [Related]
20. GOSPEL 3: Management of gout by primary-care physicians and office-based rheumatologists in France in the early 21st century - comparison with 2006 EULAR Recommendations.
Goossens J; Lancrenon S; Lanz S; Ea HK; Lambert C; Guggenbuhl P; Saraux A; Delva C; Sahbane S; Lioté F
Joint Bone Spine; 2017 Jul; 84(4):447-453. PubMed ID: 28411137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
